Burcon NutraScience Corporation
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Kip Underwood
- Full Time Employees
- 14
- Sector
- Process industries
- Industry
- Agricultural commodities/Milling
- Address
- 1946 West Broadway Vancouver BC Canada V5Z 1K5
- IPO Date
- Mar 19, 1999
- Website
- burcon.ca
- Similar Companies
- Business
- Burcon NutraScience Corporation Burcon NutraScience Corporation (TSX: BU.TO), founded in 1998 and headquartered in Vancouver, British Columbia, Canada, develops and commercializes innovative plant-based protein ingredients and technologies for the global food and beverage industries; its core portfolio includes pea protein isolates noted for solubility and neutral taste suitable for dairy alternatives, high-purity fava protein with over 90% protein content and off-white color, non-GMO canola proteins, sunflower protein such as Solatein isolate, hempseed protein, soy proteins, protein blends, and related pilot plant services from its Winnipeg Technical Centre and Galesburg production facility. The company operates subsidiaries including Burcon NutraScience (MB) Corp. and targets manufacturers of plant-based products with clean-label, sustainable solutions emphasizing superior taste, functionality, nutrition, purity, and environmental benefits derived from proprietary extraction and purification processes protected by an extensive patent portfolio. In recent developments, Burcon finalized a binding agreement in February 2025 with alliance partner ProMan, under a November 2024 strategic investor partnership led by a board member, to acquire and exclusively lease a North American protein production facility for full-scale manufacturing of its entire protein suite with production commencing in the first half of 2025; it also expanded collaborations including with Puratos for canola protein innovation, announced a $4 million convertible debenture offering in November 2025, and reported accelerating protein sales momentum in its fiscal 2026 second quarter results as customers transition to purchase orders.
Company News
Burcon NutraScience Corporation (BU:CA) Shareholder/Analyst Call Transcript
Burcon Announces Shareholder Meeting Results and Updates Commercial Guidance
Burcon Announces Annual General and Special Meeting Date
Burcon NutraScience Corporation (BU:CA) Q1 2027 Earnings Call Transcript
Burcon NutraScience Corp (BRCNF) Reports Q1 Loss, Misses Revenue Estimates
Burcon Reports Fiscal 2027 First Quarter Results, Advances Commercial Revenue Ramp
Burcon Announces Fiscal Year 2027 First Quarter Conference Call and Presentation to be Held on August 12, 2026
Are Consumer Staples Stocks Lagging Burcon NutraScience (BRCNF) This Year?
Is Burcon NutraScience (BRCNF) Stock Outpacing Its Consumer Staples Peers This Year?
Burcon NutraScience Corporation (BU:CA) Q4 2026 Earnings Call Transcript
Burcon Announces Fiscal 2026 Results
Burcon Announces Fiscal Year 2026 Conference Call and Presentation to be Held on June 24, 2026
Burcon Accelerates Growth & Achieves New Production Record
Burcon Announces Appointment of New Director
Burcon Closes Final Tranche of Non-Brokered Private Placement of Convertible Debentures of up to $6.9 Million
Burcon Achieves Record Production, Expands to More than 20 Buying Customers and Evaluates Additional Capacity Expansion
Burcon Closes Second Tranche of Non-Brokered Private Placement of Convertible Debentures of up to $6.9 Million
Burcon Announces Results of Shareholder Meeting
Burcon NutraScience Corporation (BU:CA) Shareholder/Analyst Call Prepared Remarks Transcript
Stonegate Updates Coverage on Burcon Nutrascience Corporation (BU) FY26 Q3